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 Abstract: 
Objectives – Pre-operative anemia is an established risk factor associated with 
adverse peri - operative outcomes after cardiac surgery.  However, limited 
information exists regarding the relationship between pre-operative hemoglobin and 
outcomes. The aim of this study was to investigate how outcomes are affected by pre-
operative hemoglobin concentration in a cohort of patients undergoing cardiac 
surgery. 
 
Study design – A retrospective observational cohort study. 
  
Setting – A single center tertiary referral hospital. 
 
Participants - 1972 adult patients undergoing elective and non – elective cardiac 
surgery.   
 
Interventions / Observations - The independent relationship of pre-operative 
hemoglobin concentration was explored on blood transfusion rates, return to theatre 
for bleeding and/or cardiac tamponade, post-operative intensive care unit (ICU) and 
in - hospital length of stay and mortality. 
 
Results - The overall prevalence of anemia was 32% (629 / 1972 patients).  For every 
one unit increase in hemoglobin (g/dl), blood transfusion requirements were reduced 
by 11%, 8% and 3% for red blood cell units, platelet pools and fresh frozen plasma 
units respectively (adjusted incident rate ratio 0.89 (95% CI 0.87,0.91), 0.92 
(0.88,0.97) and 0.97 (0.96,0.99).  For each one unit increase in hemoglobin (g/dl) the 
probability (over time) of discharge from ICU and hospital increased  (adjusted 
hazard ratio estimates 1.04 (1.00, 1.08) and 1.12 (1.12, 1.16) respectively). 
 
Conclusion – A lower pre – operative hemoglobin concentration results in increased 
use of hospital resources after cardiac surgery.  Each g/dl unit fall in pre – operative 
hemoglobin concentration results in increased blood transfusion requirements and 
increased post –operative ICU and hospital length of stay. 
 
Key Words:  Preoperative, hemoglobin, anemia, cardiac surgery, outcomes. 
 
 
Introduction: 
Pre-operative anemia is recognized as an independent risk factor for increased peri - 
operative morbidity and mortality after both cardiac surgery (1-6) as well as non - 
cardiac surgery (7-11).  Specifically, pre-operative anemia has been shown to be 
independently associated with major adverse cardiac and non – cardiac events 
including myocardial infarction, stroke, renal failure, prolonged ventilation, deep 
sternal wound infection, increased risk of red blood cell transfusions and an increase 
in both in - hospital and longer - term mortality.  To date, most studies have examined 
the effect of anemia, rather than pre – operative hemoglobin concentration per se on 
outcomes after cardiac surgery.  Studies examining the effect of pre-operative 
hemoglobin concentration have predominantly focused on patients undergoing 
elective coronary artery bypass graft (CABG) surgery (1-4, 12). In our view, the 
dichotomous classification of anemia poorly defines risk of adverse outcomes after 
cardiac surgery.  We hypothesize that adverse outcomes and utilization of hospital 
resources vary with pre – operative hemoglobin concentration and that the effects of 
both case mix and urgency of surgery on this are not known.  Thus this study 
examines the relationship between pre - operative hemoglobin levels and utilization of 
hospital resources and adverse outcomes, specifically blood transfusion requirements, 
length of stay, return to theatre for re – exploration for bleeding and / or cardiac 
tamponade and mortality in a cohort of patients undergoing cardiac surgery that, to 
our knowledge, has not been studied before.  
 
Methods: 
We performed a single center retrospective observational cohort study, with the aim 
of examining the relationship between pre-operative hemoglobin concentration and 
the following peri - operative and post-operative outcomes: the likelihood and amount 
of red blood cell (RBC) units, fresh frozen plasma (FFP) and platelets transfused peri-
operatively, the need to return to theatre for re-exploration for bleeding and/or cardiac 
tamponade, intensive care unit (ICU) length of stay, post-operative in-hospital length 
of stay and in - hospital mortality.   
 
The study protocol was approved by the King's College London Biomedical Research 
Department in November 2014 (R&D Number: RJ114/N302) and was given 
exemption from ethical approval.  All consecutive adult patients 16 years of age or 
older, undergoing cardiac surgery at St Thomas' Hospital, London UK, during the 
period from 1st October 2011 to 31st July 2013 were analyzed. Patients were 
excluded if they did not undergo cardiac surgery (16 patients); cardio-pulmonary 
bypass (22 patients) or no pre-operative hemoglobin data was available (3 patients).  
Therefore, 1972 patients were included in the final analysis. No formal a priori 
sample size calculation was undertaken as the main purpose of the project was to 
model relationships rather than test specific hypotheses.  The data arose from a local 
audit to examine compliance with anemia guidelines and contained near to 2000 
individuals. In clinical practice, information on patient demographics, pre-morbid risk 
factors, details of operative procedures, and post - operative outcomes are routinely 
collected. Risk factors are defined according to those used in the European System for 
Cardiac Risk Evaluation (EuroSCORE) (13). Laboratory values were obtained from 
the Electronic Patient Records Database, which routinely stores all laboratory results. 
Transfusion requirements were provided by the Guy's and St Thomas' NHS Trust 
transfusion department database.  The 24 - hour post - operative blood loss was 
measured from chest drain output, which is recorded in the Intellispace Critical Care 
and Anaesthesia (ICIP) electronic notes system.  Information from these four sources 
was amalgamated to form the study database for analysis.  Pre - operative laboratory 
values including hemoglobin and estimated glomerular filtration rate (eGFR) were 
taken to be the closest value prior to the day of surgery. Post - operative hemoglobin 
was taken as the first available value the day following surgery.  Anemia, for 
presentation and tabulation purpose, was classified according to World Health 
Organization Criteria as being <13g/dl for males and <12g/dl for females.   Length of 
ICU stay and post-operative hospital stay were defined as the time from the day of 
operation to discharge from ICU and from hospital respectively. All data including 
operative type, operative priority, and return to theatre were defined according to 
definitions used by the National Institute for Cardiovascular Outcomes Research 
(NICOR) for the Society for Cardiothoracic Surgery (SCTS) National Adult Cardiac 
Surgery Audit (14).  Red cells, platelets and fresh frozen plasma were counted as 
whole units transfused, which may have been administered at any time from the time 
of operation to the time of discharge from hospital.  
 All patients underwent general anesthesia with either a volatile or total intravenous 
anesthetic or a combination of the two. Anticoagulation was achieved with 
unfractionated heparin to an activated clotting time (ACT) > 480 seconds.  The CPB 
circuit was primed with 1000ml of Compound Sodium Lactate (Hartmann’s solution), 
500ml of Geloplasma and 250ml of 10% Mannitol.  CPB was achieved using standard 
techniques with a flow rate of 2.4 l/min/m
2
. CPB was performed with either 
normothermia, or mild – moderate hypothermia (32 – 36 degrees centigrade), unless 
specific surgery warranted lower temperatures e.g. deep hypothermic circulatory 
arrest.  Cardiac arrest was achieved with blood crystalloid cardioplegia.  After 
separation from CPB, anticoagulation was reversed with protamine sulfate. Shed 
mediastinal blood was collected and measured post-operatively but not re – infused.  
All patients were transferred to ICU post-operatively. Details of blood conservation 
strategies used in the operating room, post - operative transfusion triggers and 
discharge protocols from ICU and hospital are contained in the appendix. 
 
Data were summarized using mean and standard deviation for parametric data, 
median and interquartile ranges for non–parametric data or frequency and percentages 
for categorical data.  Descriptive statistics; T-tests, Kruskall Wallace tests and Chi-
square tests, were used to compare unadjusted outcomes.  The relationship between 
pre-operative hemoglobin and transfusion outcomes: red cell units transfused; fresh 
frozen plasma units transfused and platelets pools transfused, were explored by fitting 
a zero-inflated Poisson (ZIP) regression which allows for over dispersion due to the 
large (excess) number of patients who had zero counts (15).  The ZIP regression uses 
a mixed model approach, whereby the number of units for patients transfused is 
modeled using a standard Poisson regression model, and prediction to group 
(transfused versus not transfused) is modeled using a logistic model.  The necessity of 
the ZIP model over and above the standard Poisson regression model was assessed 
using the Vuong test.  The relationship between pre-operative hemoglobin and 
outcomes: length of hospital stay and intensive care stay, were investigated using a 
Cox proportional hazards model, where discharge was the event of interest and death 
was treated as a censoring event. The relationship between pre-operative hemoglobin 
and binary outcomes:  return to theatre and mortality, were explored using a logistic 
regression model. Two approaches to adjusting for covariates were used.  In the first 
approach the variable logistic EuroSCORE (16) was included along with mean 
corpuscular volume (MCV), body mass index, body surface area, hypertension and 
CPB time. The advantage of using the validated single measure of the logistic 
EuroSCORE for our dataset was that not all the individual variables included in the 
score were available to us at data collection. However as it is a summary measure, we 
also undertook a sensitivity analysis using all the available individual variables: age; 
gender; body mass index, body surface area, hypertension, cardiopulmonary bypass 
(CPB) time, left ventricular ejection fraction, MCV, estimated glomerular filtration 
rate based on creatinine (eGFR), previous cardiac surgery, operative priority and 
operative procedure.  Co-linearity of confounding variables was assessed by 
examining the correlation matrix and calculating the variance inflation factor (VIF). 
Variables with VIFs greater than two were discussed and the most informative 
variable based on biological plausibility was chosen for retention in the model. The 
assumption for proportional hazards was examined and tested using Schoenfeld 
residuals. Hosmer & Lemeshow goodness-of-fit test was used to assess the logistic 
regression models. All analyses were undertaken in Stata version 12. 
  
Results: 
Table 1 shows the baseline characteristics for all patients. Values are displayed as 
mean (standard deviation), median (inter-quartile range), or as a whole number 
(percentage). 
 
The majority (69%) underwent elective surgery.  Isolated CABG was the commonest 
procedure (43.7%) followed by isolated valve repair / replacement (27.9%) and 
combined CABG and valve repair / replacement (12.2%).   
 
The overall prevalence of anemia was 31.9% (629 / 1972 patients).  36.2% of female 
patients were anemic (217 / 599) and 30.0% of male patients (412 / 1373).  24.9% 
(338 / 1360) of patients presenting for elective surgery were anemic.  Patients who 
were anemic were older, more likely to be female with a lower body mass index, body 
surface area and MCV.  They had greater co-morbid disease with higher logistic 
EuroSCOREs, and higher rates of impaired renal function and left ventricular 
function.  In addition, they were more likely to have valve and aortic surgery, non - 
elective surgery, re - do surgery and had longer aortic cross clamp and CPB times. 
  
Unadjusted estimates (Table 2) showed that a falling pre – operative hemoglobin 
concentration is associated with increased transfusion of RBC units, FFP and 
platelets.  There was also a greater likelihood of returning to theatre for re-exploration 
for bleeding or cardiac tamponade, longer length of ICU stay, longer length of post-
operative in – hospital length of stay and increased mortality with each g/dl unit fall in 
pre – operative hemoglobin concentration. 
 
The adjusted estimates between pre-op hemoglobin (Table 3), and study outcomes are 
expressed as incident rate ratios (IRR), odds ratios (OR) and hazard ratios (HR) with 
95% confidence intervals and associated p values.  Both approaches to adjusting for 
covariates in the models showed good agreement for all outcomes studied.  Results 
are described for the modeling approach, which included hemoglobin as the predictor 
variable and logistic EuroSCORE as a covariate.  Interpretations of incident rate 
ratios, odds ratios and hazard ratios and the sensitivity models using hemoglobin as a 
predictor with individual covariates (Table S1) and the results for the count and 
binary equations for the zero inflated Poisson regression model (Table S2) are 
included in this manuscript but not described (see supplementary data). 
 
Reduced pre-operative hemoglobin levels are independently associated with the need 
for increased transfusion of RBC units, FFP and platelets. For every unit increase in 
pre-operative hemoglobin concentration (g/dl) it was estimated that there is a relative 
11% decrease in RBC units transfused (IRR=0.89 (0.87 - 0.91)), 8% decrease in 
number of platelet units transfused IRR=0.92 (0.88 - 0.96)) and a small but 
statistically significant 3% decrease in FFP transfused (IRR=0.97 (0.96 - 0.99).  Using 
the zero inflated Poisson model for count of RBC, Figures 1a &1b display the 
predicted probability of requirement for RBC units transfused peri-operatively and the 
predicted number of units in those at risk of transfusion by pre-operative hemoglobin 
adjusted for mean value of all other model covariates.     
 
Reduced pre-operative hemoglobin levels were found to be independently associated 
with increased length of intensive care unit and post – operative in - hospital length of 
stay. It was estimated that as pre-operative hemoglobin concentration increased the 
probability of discharge increased for ICU (HR=1.04 (1.00 - 1.08)) and for hospital 
(HR=1.12 (1.09 - 1.16)). Figure 2 shows the estimated independent effect of pre-
operative hemoglobin concentration (at 8, 11 and 13 g/dl) on predicted length of 
hospital stay adjusted for mean value of model covariates.  The median length of stay 
increases from 9 days to 13 days as hemoglobin concentration falls from 13 to 8 g/dl.   
The effect is more pronounced for those remaining in hospital the longest with length 
of stay increasing from 14 days to 26 days for the last 25
th
 centile of patients.   
 
Reduced pre-operative hemoglobin levels were not found to be independently 
associated at the 5% significance level with either an increased rate of return to 
theatre for re-exploration for bleeding and / or cardiac tamponade (OR=0.91 (0.82 - 
1.01) p=0.083), nor increased mortality (OR=0.88 (0.76 - 1.01) p=0.073). 
 
Discussion: 
 
After adjusting for the confounding effects of age, gender, co-morbidity, case – mix, 
operative priority, re-do surgery (as defined by logistic EuroSCORE) and other risk 
factors including MCV, body mass index and surface area, hypertension and length of 
cardiopulmonary bypass, we have shown that lower pre-operative hemoglobin 
concentrations are independently associated with increased utilization of hospital 
resources.  Specifically, as pre-operative hemoglobin concentration falls there are 
increased transfusion requirements of blood products, prolonged ICU and post-
operative in – hospital length of stay. 
 
A few studies have examined the independent effects of pre-operative hemoglobin 
concentration on post-operative outcomes in patients undergoing coronary artery 
bypass graft surgery (CABG).  Bell et al.  (12) investigated the relationship between a 
pre – operative hemoglobin level less than 10 g/dl and 30 - day operative mortality 
and peri – operative morbidity in a predominantly male population of 36,358 patients 
undergoing CABG.  They concluded that whilst pre – operative hemoglobin was 
significant in univariate analysis, it was not an independent predictor of adverse 
outcomes suggesting confounding with other variables.  However, others have found 
pre – operative hemoglobin concentration to be independently predictive of adverse 
outcomes.  In a retrospective multivariate analysis of 182,599 patients undergoing 
CABG, Williams et al. (4) found a higher odds of death, renal failure, deep sternal 
wound infection and post-operative length of stay for each 5% decrease in pre-
operative hematocrit.  Kulier et al. (2) found that lower pre-operative hemoglobin 
concentrations were an independent predictor of adverse non – cardiac outcomes 
including cerebral and renal events in 4804 patients undergoing elective CABG 
surgery in a prospective multicenter study.  
 
Our findings demonstrate the independent relationship between pre – operative 
hemoglobin concentration, utilization of hospital resources and adverse outcomes in a 
cohort of patients undergoing cardiac surgery different to previous studies (2, 4, 12). 
We report in our study that a rise in pre-operative hemoglobin by 1g/dl is associated 
with a relative 11% decrease in the likelihood of red cell transfusion, an 8% decrease 
in the likelihood of requiring platelets and 3% decrease in the likelihood of requiring 
fresh frozen plasma independent of other confounding variables.  In Figures 1a and 
Figure 1b we have presented the estimated independent relationship between pre-
operative hemoglobin concentration and the probability and amount of RBC units 
transfused peri-operatively.  We used a ZIP model, as many patients did not receive a 
transfusion, thus we required a model that could account for the non-standard 
distribution of RBC units (due to the ‘large’ number of zero transfusions in the 
cohort). The number of predicted RBC units was found to be higher than our clinical 
experience would suggest. There are two possible reasons for this: the predicted count 
was based on mean level of covariates and this ‘average’ patient does not exist in 
clinical practice.  Secondly, in the model the log count is assumed to change linearly 
with the predictor variable, and while this seems to holds well for the lower and 
middle pre-operative hemoglobin values, the linear relationship may contribute to 
over-estimation of RBC units for higher pre-operative hemoglobin values. As this 
model was developed in a single cohort and has not been externally validated, results 
presented in this paper should not be used for predictive purposes but rather should be 
viewed as describing this independent relationship. 
 
The association with a lower pre – operative hemoglobin concentration and prolonged 
length of stay has been reported elsewhere. Williams et al. (4) found that a reduction 
of pre-operative hematocrit by 5% was associated with 10% higher odds of remaining 
in hospital greater than 14 days.  The cohort, study design and also organizational 
differences in the way patients are discharged from hospital care, may in part explain 
differences in findings between studies with regards to post-operative length of stay. 
However, in this study we found that lower pre-operative hemoglobin levels were 
independently associated with a reduced probability of discharge from both hospital 
and ICU.  We have described the dramatic effect of a falling pre-operative 
hemoglobin concentration on post – operative length of stay and have estimated its 
effect in Figure 2.  
  
This study may be underpowered to detect differences with low event rates e.g. 
mortality (3.7% in our cohort).  Previous studies, using either larger sample sizes or 
different methodologies e.g. composite outcomes including mortality, have found pre 
– operative hemoglobin concentration to be independently associated with mortality.  
Williams et al. (4) who found in 182,599 patients undergoing CABG surgery that a 
5% decrease in pre-operative hematocrit was independently associated with an 8% 
higher odds of death and van Straten et al. (3) concluded that lower pre-operative 
hemoglobin concentrations were independently associated with late (greater than 30 
day) mortality in 10, 025 patients undergoing CABG.  Karkouti et al. (5) in a 
retrospective analysis of 3500 cardiac surgery patients found that pre-operative 
anemia was not significantly associated with increased 30-day mortality after 
propensity matching, though this was significant when included as part of a composite 
outcome with acute kidney injury and stroke. 
 
This study highlights the importance of the adverse effect of a falling pre-operative 
hemoglobin concentration on utilization of hospital resources including increased 
blood transfusion requirements and prolonged length of stay post – operatively in the 
intensive care unit and in hospital.  We argue that clinicians should view pre – 
operative hemoglobin concentration, rather than anemia, as an independent risk factor 
as there are increasing utilization of hospital resources with each g/dl unit fall in pre – 
operative hemoglobin concentration.  Reasons why pre – operative hemoglobin 
concentration may be a more useful marker than anemia status include that anemia, as 
defined by WHO criteria, is a late marker of iron deficiency.  It has also been argued 
that it may be inappropriate to define anemia by different values with respect to 
gender in a surgical population where blood loss has a proportionately greater effect 
on circulating blood volume in females(17). It is tempting to speculate whether 
treatment will lead to an improvement in post-operative outcomes.  The potential 
implications of reducing transfusions requirements make targeting pre-operative 
hemoglobin concentration an attractive avenue for further study.  Guidelines (based 
on a Class II a recommendation) advising the treatment of pre-operative anemia in 
cardiac surgery exist (18) though have a limited evidence base (level of evidence B).  
Nevertheless, there is evidence that pre-operative use of both iron (19) and 
erythropoietin (20)  reduces allogeneic blood transfusion. Cladellas et al. (21) also 
reported improvements in mortality and hospital stay as well as reduced blood 
transfusions following intravenous iron and erythropoietin, although this single center 
study used a historical cohort for comparison, and their results have yet to be re-
produced in other studies.  However, adequately designed and powered efficacy and 
safety trials are still required to determine what role iron and erythropoietin have as 
transfusion avoidance strategies in cardiac surgery and other surgical settings (22). 
 
We acknowledge the limitations of the design of the study, a single – center 
retrospective observational study.  The inherent limitations of retrospective 
observational data reflects what actually happened in clinical practice, for example, 
the lack of a specific transfusion trigger in the operating room.  The single center 
design means that the sample size is limited and may be underpowered to detect 
outcomes with low event rates e.g. mortality. However, the benefit of this single 
center design is that we employ a uniform process of peri-operative care including 
blood conservation strategies in the operating room, transfusion triggers in the ICU 
and discharge protocols from intensive care (23) and hospital (Appendix).  Causality 
cannot be established from this study and it is possible that confounding factors may 
still influence the outcomes studied despite multivariate analysis. We chose to 
examine blood transfusion as an outcome measure of hospital resources rather than 
include it as a covariate, thus the effects of blood transfusions themselves are a 
potential confounding factor.  Some may view looking at blood transfusion as an 
outcome measure redundant in that it may seem obvious that patients with a lower pre 
– operative hemoglobin concentration will be transfused more often.  However, we 
felt that it was important to examine this relationship as blood transfusions themselves 
have been implicated in causing adverse outcomes after cardiac surgery (24, 25) as 
well as having significant cost implications.  Finally, the transfusion trigger that we 
used in our ICU at the time of the study may seem relatively high compared to a non 
– cardiac ICU population (26).  It was chosen to reflect our patient population 
undergoing cardiac surgery many of whom had coronary artery disease, myocardial 
ischaemia and the potential for post –operative blood loss.  Indeed, it remains unclear 
as to the optimal hemoglobin concentration peri - operatively and whether a liberal or 
restrictive transfusion policy is superior in patients undergoing cardiac surgery (27, 
28). 
 
In conclusion, lower pre-operative hemoglobin concentrations are independently 
associated with increased utilization of hospital resources after cardiac surgery.  Each 
g/dl unit fall in pre-operative hemoglobin concentration is independently associated 
with increased transfusion requirements of blood products and increased post - 
operative length of stay in intensive care and in hospital.  To highlight this, we argue 
that clinicians should consider an abnormal pre – operative hemoglobin concentration 
and of course its underlying cause as a risk factor for increased utilization of hospital 
resources and potentially other adverse outcomes, rather than simply the binary 
phenomenon of anemia status. Further prospective evaluation is necessary to 
determine what hemoglobin concentration is optimal for patients undergoing cardiac 
surgery and whether an intervention to optimize pre - operative hemoglobin 
concentration is cost effective and improves patient outcomes or utilization of hospital 
resources. 
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FIGURE LEGENDS 
 
Figure 1a:  The predicted number of Red cell units (RCU) transfused peri-operatively 
in those at risk of transfusion by pre-operative hemoglobin adjusted for mean value of 
all other model covariates.  
 
Figure 1b:  The predicted probability of requirement for Red cell units (RCU) 
transfused peri-operatively by pre-operative hemoglobin adjusted for mean value of 
all other model covariates. 
 
 
Figure 2:  The estimated independent effect of pre-operative hemoglobin 
concentration (at 8, 11 and 13 g/dl) on predicted probability of remaining in hospital 
adjusted for mean value of model covariates. 
 
  
  
Table 1:  Baseline demographics and peri – operative characteristics for all patients. 
  Demographics All patients (N=1972) 
Pre-op Age (years), Median (IQR) 68.2 (59.0 - 75.4) 
 
Male, n (%) 1373 (69.6) 
 
Pre-op haemoglobin (g/dl), Median (IQR) 13.4 (12.2 - 14.4) 
 
MCV, Mean (SD) 91.9 (5.7) 
 
eGFR (ml/min/1.73m2), Mean (SD) 73.6  (23.6) 
 
LVEF: poor, n (%) 500 (26.0) 
 
LVEF: moderate, n (%) 70 (3.6) 
 
Logistic Euroscore, Median (IQR) 3.8 (1.8 - 7.5) 
 
Hypertension, n (%) 1306 (66.5) 
 
Previous Cardiac Surgery, n (%) 145 (7.4) 
 
BMI, Mean (SD) 28.3 (5.4) 
  
BSA, Mean (SD) 1.92 (0.22) 
Peri-op Operative Priority - Elective, n (%) 1360 (69.0) 
 
Operative Priority - Urgent, n (%) 512 (26.0) 
 
Operative Priority - Emergency, n (%) 92 (4.7) 
 
Operative Priority - Salvage, n (%) 8 (0.4) 
 
Type of Operation - CABG only, n (%) 861 (43.7) 
 
Type of operation - Valve only, n (%) 550 (27.9) 
 
Type of Operation - CABG and valve, n (%) 240 (12.2) 
 
Type of operation - Major Aortic, n (%) 153 (7.8) 
 
Type of operation - Other, n (%) 168 (8.5) 
 
24 Hour Drain output (mls), Median (IQR)  600 (380 - 895) 
 
Cardiopulmonary Bypass Time (mins), Median (IQR) 87 (70 - 110) 
  
X-Clamp Time (mins), Median (IQR) 57 (43 - 79) 
 
  
 Table 2:  Summary of outcomes for all patients and by pre-operative haemoglobin 
concentration 
      
pre-operative haemoglobin concentration 
(g/dl)    
Study outcomes 
summ
ary 
measu
re 
All 
patie
nts 
(N=1
972) 
≤9 
n=
47 
9-
10 
n=
68 
10-
11 
n=
10
8 
11-
12 
n=
21
5 
12-
13 
n=
35
7 
13-
14 
n=
50
4 
14-
15 
n=
39
8 
≥1
5 
n=
27
5 
P-
val
ue  
Red Cell Units 
Transfused 
% with 
zero  51.7 2.1 5.9 
14.
8 
19.
5 
38.
9 
58.
9 
75.
9 
79.
6 
<0.
001 
  
% with 
one  9.7 0.0 4.4 7.4 
18.
1 
14.
9 
12.
9 3.5 3.3 
  
  
% with 
≥ two 38.6 
97.
9 
89.
7 
44.
8 
62.
3 
46.
2 
28.
2 
20.
6 
17.
1 
  
Fresh Frozen Plasma 
Units Transfused 
% with 
zero  73.8 
38.
3 
47.
1 
68.
5 
66.
5 
72.
8 
78.
2 
81.
9 
75.
6 
<0.
001 
  
% with 
one  0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
  
  
% with 
≥ two 26.2 
61.
7 
52.
9 
31.
5 
33.
5 
27.
2 
21.
8 
18.
1 
24.
4 
  
Platelets Pools 
Transfused 
% with 
zero  72.2 
29.
8 
42.
7 
60.
2 
67.
4 
72.
0 
78.
0 
79.
2 
74.
9 
<0.
001 
  
% with 
one  15.6 
27.
7 
27.
9 
19.
4 
13.
5 
16.
8 
13.
7 
13.
3 
15.
6 
  
  
% with 
≥ two 12.2 
42.
6 
29.
4 
20.
4 
19.
1 
11.
2 8.3 7.5 9.5 
  
Return to theatre, n 
(%) 
% 
return 8.1 
20.
5 
18.
5 
11.
9 7.8 6.4 7.9 6.7 6.8 
0.0
01 
Mortality, n  (%) % died 
3.65 
19.
2 7.4 8.3 
6.0
5 2.5 2.2 2 2.9 
<0.
001 
Post op length of 
stay, days 
Media
n 9 25 18 14 12 9 8 8 8 
<0.
001 
  
IQR 
7,15 
17,
40 
13, 
27 
9, 
28 
8, 
22 
7, 
15 
7, 
13 
6, 
12 
6, 
11 
  
Intensive Care Unit 
length of stay, days  
Media
n 1 6 2 2 1 1 1 1 1 
<0.
001 
  
IQR 
1,2 
2,2
1 
1, 
7 1,4 1,4 1,2 1,2 1,2 1,2 
  
 
  
  
Table 3:  Multivariate regression model estimates with pre – operative haemoglobin 
(Hb) as a continuous predictor and covariates: logistic EuroSCORE; MCV; BMI; 
BSA; hypertension; CPB time. 
 
Model 1 Outcome  IRR 95% CIs P value 
ZIP: count Red Cell Units Transfused 
 
0.89 
0.87, 0.91 
<0.001 
ZIP: count Fresh Frozen Plasma Units Transfused 
 
0.97 0.96,0.99 0.010 
ZIP: count Platelets Pools Transfused 
 
0.92 0.88,0.96 <0.001 
Model 1 Outcome 
 
OR 95% CIs P value 
Logistic Return to theatre  0.91 0.82, 1.01 0.083 
Logistic Mortality  0.88 0.76, 1.01 0.073 
Model 1 Outcome 
 
HR 95% CIs P value 
Cox PH Discharge from hospital   1.12 1.09, 1.16 <0.001 
Cox PH Discharge from ICU  1.04 1.00, 1.08 0.019 
 
 
